CN107106633A - 内服用组合物 - Google Patents

内服用组合物 Download PDF

Info

Publication number
CN107106633A
CN107106633A CN201580069149.8A CN201580069149A CN107106633A CN 107106633 A CN107106633 A CN 107106633A CN 201580069149 A CN201580069149 A CN 201580069149A CN 107106633 A CN107106633 A CN 107106633A
Authority
CN
China
Prior art keywords
composition
component
lactoferrin
fucoxanthin
fat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580069149.8A
Other languages
English (en)
Chinese (zh)
Inventor
森下聪
中村佳菜惠
大原胜义
关桂子
小野知二
上北健
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of CN107106633A publication Critical patent/CN107106633A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
CN201580069149.8A 2014-12-19 2015-12-18 内服用组合物 Pending CN107106633A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014257747A JP6399920B2 (ja) 2014-12-19 2014-12-19 体脂肪低減剤、体重減少促進剤、血中中性脂肪低減剤及び血中遊離脂肪酸低減剤
JP2014-257747 2014-12-19
PCT/JP2015/085450 WO2016098874A1 (ja) 2014-12-19 2015-12-18 内服用組成物

Publications (1)

Publication Number Publication Date
CN107106633A true CN107106633A (zh) 2017-08-29

Family

ID=56126754

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580069149.8A Pending CN107106633A (zh) 2014-12-19 2015-12-18 内服用组合物

Country Status (5)

Country Link
JP (1) JP6399920B2 (enExample)
KR (1) KR20170095843A (enExample)
CN (1) CN107106633A (enExample)
TW (1) TWI691334B (enExample)
WO (1) WO2016098874A1 (enExample)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101721403A (zh) * 2008-10-16 2010-06-09 北京绿色金可生物技术股份有限公司 岩藻黄素在减肥方面的应用
CN103012327A (zh) * 2012-12-21 2013-04-03 国家海洋局第三海洋研究所 岩藻黄质的制备方法
CN103327999A (zh) * 2011-01-21 2013-09-25 狮王株式会社 促进脂肪分解组合物
WO2014028585A1 (en) * 2012-08-14 2014-02-20 The Texas A&M University System Compositions for targeted anti-aging therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006083102A (ja) * 2004-09-16 2006-03-30 Four Leaf Japan:Kk 抗酸化組成物およびこれを含む製品
CA2609454A1 (en) * 2005-05-24 2006-11-30 National University Corporation Hokkaido University Agent having antiobesity activity and method of inhibiting obesity
JP5158307B2 (ja) * 2006-09-15 2013-03-06 ライオン株式会社 脂肪減少促進剤及び代謝異常症候群改善薬
JP2011001333A (ja) * 2009-06-22 2011-01-06 Lion Corp アシル−ＣｏＡ合成阻害剤
JP2013060402A (ja) * 2011-09-14 2013-04-04 Furabamin:Kk フコキサンチンおよびフコイダン含有組成物
JP6208604B2 (ja) * 2014-03-14 2017-10-04 ライオン株式会社 体脂肪低減剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101721403A (zh) * 2008-10-16 2010-06-09 北京绿色金可生物技术股份有限公司 岩藻黄素在减肥方面的应用
CN103327999A (zh) * 2011-01-21 2013-09-25 狮王株式会社 促进脂肪分解组合物
WO2014028585A1 (en) * 2012-08-14 2014-02-20 The Texas A&M University System Compositions for targeted anti-aging therapy
CN103012327A (zh) * 2012-12-21 2013-04-03 国家海洋局第三海洋研究所 岩藻黄质的制备方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MI-JIN YIM ET AL.: ""Suppressive Effects of Amarouciaxanthin A on 3T3-L1 Adipocyte"", 《JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY》 *
健康生活图书编委会编著: "《3高营养调理手册》", 30 November 2010, 吉林科学技术出版社 *
刘莹: "《豆浆米糊果汁》", 28 February 2014, 上海科学普及出版社 *
李斌等: "海带渣中岩藻黄素的酶法提取工艺研究", 《食品工业科技》 *

Also Published As

Publication number Publication date
JP6399920B2 (ja) 2018-10-03
KR20170095843A (ko) 2017-08-23
WO2016098874A1 (ja) 2016-06-23
TWI691334B (zh) 2020-04-21
TW201625293A (zh) 2016-07-16
JP2016117676A (ja) 2016-06-30

Similar Documents

Publication Publication Date Title
EP2413952B1 (en) Improvement in promotion of healthy catch-up growth
KR101361603B1 (ko) 체내 지질 개선 조성물
JP2005068060A (ja) ラクトフェリンを含有する医薬組成物ならびに加工食品の製造法
JP5271454B2 (ja) アルコール性障害緩和剤
KR20080108523A (ko) 지방 축적 억제제
EP2879713B1 (en) Compounds and their effects on appetite control and insulin sensitivity
EP2908828A1 (en) Galactagogue compositions based on phosphatidylserine
TW202019863A (zh) 組成物及其用途
TWI691334B (zh) 內服用組成物、製劑、與用途
WO2012060718A1 (en) Preventing or treating metabolic syndrome by administering a trans fatty acid, or a salt, ester or precursor thereof, or sialic acid in free or bound form
JP5955236B2 (ja) 血中クレゾール低下剤
KR102629192B1 (ko) 분지쇄 케토산 (bcka)의 혼합물 및 이러한 혼합물의 제조 방법
JP2008069121A (ja) 脂肪減少促進剤
CN102631370B (zh) 一种预防或改善高脂血症及补充维生素d的组合物
TWI442920B (zh) 香椿萃取物於減少體重或以降低體脂肪之藥物上之用途
CN109364202B (zh) 一种组合物及其制备方法和应用
EP2815756B1 (en) Composition for preventing, ameliorating or treating metabolic syndrome
JP2004002254A (ja) 植物抽出エキスを含有する腸溶性の脂肪吸収抑制剤およびそれを含有する食品
JP2012214415A (ja) 血清善玉コレステロール増加促進用医薬品又は食品
WO2019225653A1 (ja) Ｇｉｐ上昇抑制剤
JP2020015712A (ja) 四肢スリミング剤
CN109953242A (zh) 一种具有降血糖、降血脂作用的西番莲多元营养饮品其制备方法及应用
TW201828967A (zh) 發芽米萃取物的用途
TW201630598A (zh) 用於製造與人類凝乳酶的活性相關疾病之預防治療用藥劑之具有黃酮醇骨架之化合物或其藥學上容許之鹽的用途
JP2012121909A (ja) 脂肪減少促進剤

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170829